Erratum: Performance of hemodialysis with novel medium cut-off dialyzers (Nephrology Dialysis Transplantation (2016) (gfw310) DOI: 10.1093/ndt/gfw310);Performance of hemodialysis with novel medium cut-off dialyzers

Nephrology Dialysis Transplantation

Volumn 32, Issue 1, 2017, Pages 165-172

  Kirsch, Alexander H ^a   Lyko, Raphael ^b   Nilsson, Lars Göran ^c   Beck, Werner ^d   Amdahl, Michael ^e   Lechner, Petra ^f   Schneider, Andreas ^b   Wanner, Christoph ^b   Rosenkranz, Alexander R ^a   Krieter, Detlef H ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c Gambro AB   (Sweden)

^d Gambro Dialysatoren GmbH   (Germany)

^e BAXTER HEALTHCARE CORPORATION   (United States)

^f LKH Hochsteiermark   (Austria)

Author keywords

Beta2 microglobulin; Dialysis; Hemodiafiltration; Hemodialysis; Uremic toxins

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; COMPLEMENT FACTOR D; IMMUNOGLOBULIN LAMBDA CHAIN; MYOGLOBIN; ALBUMINOID; ALPHA GLOBULIN; ALPHA-1-MICROGLOBULIN; ARTIFICIAL MEMBRANE;

ARTICLE; ARTIFICIAL KIDNEY; DEVICE SAFETY; DYSPNEA; HEADACHE; HEMODIAFILTRATION; HEMODIALYSIS; HIGH FLUX DIALYZER; HUMAN; LIGHT CHAIN; MEDICAL DEVICE COMPLICATION; MEDIUM CUT OFF DIALYZER; MUSCLE CRAMP; NAUSEA; OPEN STUDY; PILOT STUDY; PROSPECTIVE STUDY; PROTEIN DEPLETION; RANDOMIZED CONTROLLED TRIAL (TOPIC); VOMITING; AGED; ARTIFICIAL MEMBRANE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; PERMEABILITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AGED; ALBUMINS; ALPHA-GLOBULINS; CROSS-OVER STUDIES; FEMALE; HEMODIAFILTRATION; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PERMEABILITY; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 85016212157     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfaa322     Document Type: Erratum

References (48)

1. Duranton F, Cohen G, De Smet R et al. Normal and pathologic concentrations of uremic toxins. J AmSoc Nephrol 2012; 23: 1258-1270
2. Vanholder R, De Smet R, GlorieuxGet al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943
3. Vanholder RC, Eloot S, Glorieux GL. Future avenues to decrease uremic toxin concentration. Am J Kidney Dis 2016; 67: 664-676
4. Cohen G, Haag-Weber M, Mai B et al. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 1995; 6: 1592-1599
5. Cohen G, Rudnicki M, Horl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int Suppl 2001; 78: S48-S52
6. Vanholder R, Schepers E, Pletinck A et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: A systematic review. J Am Soc Nephrol 2014; 25: 1897-1907
7. Desjardins L, Liabeuf S, Lenglet A et al. Association between free light chain levels, and disease progression and mortality in chronic kidney disease. Toxins 2013; 5: 2058-2073
8. Lisowska-Myjak B. Uremic toxins and their effects on multiple organ systems. Nephron Clin Pract 2014; 128: 303-311
9. Assi LK, McIntyre N, Fraser S et al. The association between polyclonal combined serum free light chain concentration and mortality in individuals with early chronic kidney disease. PLoS ONE 2015; 10: e0129980
10. Haynes R, Hutchison CA, Emberson J et al. Serum free light chains and the risk of ESRD and death in CKD. Clin J Am Soc Nephrol 2011; 6: 2829-2837
11. Hutchison CA, Burmeister A, Harding SJ et al. Serum polyclonal immunoglobulin free light chain levels predict mortality in people with chronic kidney disease.Mayo Clin Proc 2014; 89: 615-622
12. DiRaimondo CR, Pollak VE. Beta 2-microglobulin kinetics in maintenance hemodialysis: A comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse. Am J Kidney Dis 1989; 13: 390-395
13. Locatelli F, Mastrangelo F, Redaelli B et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996; 50: 1293-1302
14. Ward RA, Schmidt B, Hullin J et al. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 2000; 11: 2344-2350
15. Boschetti-de-Fierro A, Voigt M, Storr M et al. MCO membranes: enhanced selectivity in high-flux class. Sci Rep 2015; 5: 18448
16. Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20: 645-654
17. Krane V, Krieter DH, Olschewski M et al. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 2007; 49: 267-275
18. Chauveau P, Nguyen H, Combe C et al. Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 2005; 45: 565-571
19. Nistor I, Palmer SC, Craig JC et al. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis 2014; 63: 954-967
20. Grooteman MPC, van den Dorpel MA, Bots ML et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012; 23: 1087-1096
21. Maduell F, Moreso F, Pons M et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013; 24: 487-497
22. Ok E, Asci G, Toz H et al.Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013; 28: 192-202
23. Bock AH, Paul B. Efficient removal of beta2 microglobulin and leptin by online hemodiafiltration: comparison of three state of the art dialyzers. In: Kidney Week 2013, Atlanta, GA, 2013. Abstract SA-PO404, p. 718A. American Society of Nephrology,Washington, DC, USA
24. Basile C, Libutti P, Di Turo AL et al. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. Nephrol Dial Transplant 2011; 26: 1296-1303
25. Yeh KC, Kwan KC. A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J Pharmacokinet Biopharm 1978; 6: 79-98
26. Schneditz D, Putz-Bankuti C, Ribitsch W et al. Correction of plasma concentrations for effects of hemoconcentration or hemodilution. ASAIO J 2012; 58: 160-162
27. Bergström J,Wehle B. No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987; 1: 628-629
28. Tattersall JE, Ward RA, EUDIAL group. Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant 2013; 28: 542-550
29. Golper TA. Is hemodiafiltration ready for broader use? Kidney Int 2015; 88: 940-942
30. Cohen G, Hörl WH. Free immunoglobulin light chains as a risk factor in renal and extrarenal complications. Semin Dial 2009; 22: 369-372
31. Anandram S, Assi LK, Lovatt T et al. Elevated, combined serum free light chain levels and increased mortality: A 5-year follow-up, UK study. J Clin Pathol 2012; 65: 1036-1042
32. Dispenzieri A, Katzmann JA, Kyle RA et al. Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population. Mayo Clin Proc 2012; 87: 517-523
33. Lamy T, Henri P, Lobbedez T et al. Comparison between on-line highefficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal. Blood Purif 2014; 37: 93-98
34. Bourguignon C, Chenine L, Bargnoux AS et al. Hemodiafiltration improves free light chain removal and normalizes j/k ratio in hemodialysis patients. J Nephrol 2016; 29: 251-257
35. Fabbrini P, Sirtori S, Casiraghi E et al. Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties. Blood Purif 2013; 35(Suppl 2): 52-58
36. OshiharaW, Nagao H, Megano H et al. Trial use of a polymethylmethacrylatemembrane for the removal of free immunoglobulin light chains in dialysis patients. NDT Plus 2010; 3: i3-i7
37. Canaud B, Barbieri C, Marcelli D et al. Optimal convection volume for improving patient outcomes in an international incident dialysis cohort treated with online hemodiafiltration. Kidney Int 2015; 88: 1108-1116
38. Krieter DH, Canaud B. High permeability of dialysis membranes: what is the limit of albumin loss? Nephrol Dial Transplant 2003; 18: 651-654.
39. Kaplan AA, Halley SE, Lapkin RA et al. Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995; 47: 573-578
40. Samtleben W, Dengler C, Reinhardt B et al. Comparison of the new polyethersulfone high-flux membrane DIAPES HF800 with conventional highflux membranes during on-line haemodiafiltration. Nephrol Dial Transplant 2003; 18: 2382-2386
41. Meert N, Eloot S, Schepers E et al. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transplant 2011; 26: 2624-2630
42. Ward RA. Protein-leaking membranes for hemodialysis: A new class of membranes in search of an application? J AmSocNephrol 2005; 16: 2421-2430
43. Caravaca F, Arrobas M, Dominguez C. Serum albumin and other serum protein fractions in stable patients on peritoneal dialysis. Perit Dial Int 2000; 20: 703-707
44. Fiedler R, Neugebauer F, Ulrich C et al. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein. Artif Org 2012; 36: 886-893
45. Daugirdas JT. Physiologic principles and urea kinetic modeling. In: JT Daugirdas, PG Blake, TS Ing (eds). Handbook of Dialysis. Philadelphia, PA: LippincottWilliams & Wilkins, 2007, pp. 25-58.
46. Maduell F, Arias-Guillen M, Fontseré N et al. Elimination of large uremic toxins by a dialyzer specifically designed for high-volume convective therapies. Blood Purif 2014; 37: 125-130
47. Schindler R, Ertl T, Beck W et al. Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes. Blood Purif 2006; 24: 203-211
48. Hulko M, Gekeler A, Koch I et al. Dialysis membrane pore size does not determine LPS retention. Nephrol Dial Transplant 2015; 30(Suppl 3): iii244.